Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors
JCO Precis Oncol
.
2019 May 16:3:PO.19.00009.
doi: 10.1200/PO.19.00009.
eCollection 2019.
Authors
Ezra Y Rosen
1
,
Alison M Schram
1
2
,
Robert J Young
1
,
Mark W Schreyer
1
,
Jaclyn F Hechtman
1
,
Catherine A Shu
3
,
Nora C Ku
4
,
David M Hyman
1
2
,
Alexander Drilon
1
2
Affiliations
1
Memorial Sloan Kettering Cancer Center, New York, NY.
2
Weill Cornell Medical College, New York, NY.
3
Columbia University, New York, NY.
4
Loxo Oncology, Stamford, CT.
PMID:
32914009
PMCID:
PMC7446323
DOI:
10.1200/PO.19.00009
No abstract available
Publication types
Case Reports
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States
R01 CA226864/CA/NCI NIH HHS/United States
T32 CA009512/CA/NCI NIH HHS/United States